Literature DB >> 12860899

Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure.

Philip B Adamson1, Karen J Kleckner, Warren L VanHout, Sriram Srinivasan, William T Abraham.   

Abstract

BACKGROUND: Cardiac resynchronization therapy (CRT) using biventricular pacing improves symptoms and functional capacity in patients with moderate to severe heart failure. The present study examined whether an improvement in ventricular performance from resynchronization therapy changes the autonomic control of heart rate. METHODS AND
RESULTS: Heart rate variability (HRV) was examined in 50 patients implanted with the InSync biventricular pacing system who were randomized to therapy-on (n=25) or therapy-off (n=25). HRV was computed as the standard deviation of the atrial cycle length sensed from the system over 2 months of continuous monitoring. HRV was compared between CRT-on and CRT-off groups. HRV was higher in patients randomized to CRT-on compared with CRT-off (148+/-47 ms for CRT-on versus 118+/-45 ms for CRT-off; P=0.02), despite the lack of difference in mean atrial cycle length (844+/-129 ms for CRT-on versus 851+/-110 ms for CRT-off; P=0.82). Changes in plasma catecholamines were not different between the CRT-on and CRT-off groups from baseline to the 3-month follow-up.
CONCLUSIONS: Improvement in ventricular performance from CRT shifts cardiac autonomic balance toward a more favorable profile that is less dependent on sympathetic activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12860899     DOI: 10.1161/01.CIR.0000083368.75831.7A

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  28 in total

Review 1.  Implantable cardiac resynchronization therapy devices to monitor heart failure clinical status.

Authors:  Jeffrey Wing-Hong Fung; Cheuk-Man Yu
Journal:  Curr Heart Fail Rep       Date:  2007-03

Review 2.  The role of the autonomic nervous system in sudden cardiac death.

Authors:  Marmar Vaseghi; Kalyanam Shivkumar
Journal:  Prog Cardiovasc Dis       Date:  2008 May-Jun       Impact factor: 8.194

Review 3.  Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: new insights from continuous monitoring devices.

Authors:  Philip B Adamson
Journal:  Curr Heart Fail Rep       Date:  2009-12

4.  Potential pro-arrhythmic effect of cardiac resynchronization therapy.

Authors:  Osama Tayeh; Waleed Farouk; Abdo Elazab; Hassan Khald; Antonio Curnis
Journal:  J Saudi Heart Assoc       Date:  2013-05-30

Review 5.  The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction.

Authors:  John S Floras; Piotr Ponikowski
Journal:  Eur Heart J       Date:  2015-05-13       Impact factor: 29.983

6.  Glycoproteins identified from heart failure and treatment models.

Authors:  Shuang Yang; Lijun Chen; Shisheng Sun; Punit Shah; Weiming Yang; Bai Zhang; Zhen Zhang; Daniel W Chan; David A Kass; Jennifer E van Eyk; Hui Zhang
Journal:  Proteomics       Date:  2014-10-09       Impact factor: 3.984

7.  Therapeutic implications of implantable device-based monitoring of patients with heart failure.

Authors:  Eric Popjes; John P Boehmer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-09

8.  Atrioventricular Nodal Catheter Ablation in Atrial Fibrillation Complicating Congestive Heart Failure.

Authors:  Osmar Antonio Centurión; Karina Elizabeth Scavenius; Laura B García; Luis Miño; Judith Torales; Orlando Sequeira
Journal:  J Atr Fibrillation       Date:  2018-06-30

Review 9.  Cardiac resynchronization therapy and its potential proarrhythmic effect.

Authors:  Indranill Basu Ray; Lahn Fendelander; Jagmeet P Singh
Journal:  Clin Cardiol       Date:  2007-10       Impact factor: 2.882

Review 10.  Resynchronization therapy in the context of atrial fibrillation: benefits and limitations.

Authors:  Uta C Hoppe
Journal:  J Interv Card Electrophysiol       Date:  2007-04-21       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.